Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children
Recruiting
N/A
Interventional Study
Attention Deficit Hyperactivity Disorder
At a Glance
- Age
- 6 – 12
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 68 (estimated)
- Sponsor
- Khyber Medical University Peshawar · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This randomized controlled trial will evaluate the effectiveness of neuroplasticity-targeted supplements on neuroinflammatory markers and ADHD symptoms in children aged 6 to 12 years diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Participants will be randomly assigned to one of four groups: gut-targeted supplements (prebiotics and probiotics), brain-targeted supplements (omega-3 f…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* DSM-5 confirmed ADHD diagnosis
* Age 6-12 years
* Medication-free or on stable stimulant medication (≥1 month)
Exclusion Criteria:
* Antibiotic use in last 4 weeks
* Gastrointestinal disorders
* Neurological comorbidities (e.g., epilepsy)
* Severe food allergies
Contacts